logo-large
  • Browse Categories

Publications by authors named "Cathy Sprague"

Claim this Profile
E
ERBB2 Amplification and HER2 Expression in Salivary Duct Carcinoma: Evaluation of Scoring Guidelines and Potential for Expanded Anti-HER2 Therapy.
John L McAfee, Raza S Hoda, Carrie Hoyle, Lauren McCoy, Cathy Sprague

Mod Pathol· October 2023


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2 IHC Expression and Gene Amplification in p53-aberrant High-grade Endometrial Endometrioid Carcinoma Suggests That This Population May Benefit From HER2 Testing and Targeted Therapy.
Amy S Joehlin-Price, Miglena K Komforti, Nicholas R Ladwig, Patrick Devine, Carrie Hoyle, Cathy Sprague

Am J Surg Pathol· May 2023


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Pathologic Features Associated With Invasive Breast Carcinoma With 2018 American Society of Clinical Oncology/College of American Pathologists In Situ Hybridization Group 2 Results (Human Epidermal Growth Factor Receptor 2 [HER2]/Chromosome 17 Centromere [CEP17] Ratio ≥2.0 and Average HER2 Copy Number <4.0).
Raza S Hoda, Shabnam Zarei, Patrick J McIntire, Cathy Sprague, Yasmin Mekhail

Arch Pathol Lab Med· June 2022


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: